Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios

Carlos E. Figueroa Castro, Louis Palen, Carrie Johnson, Mary Beth Graham, David Letzer, Nathan Ledeboer, Blake Buchan, Timothy Block, Heather Seliger, Siddhartha Singh, Elizabeth Behrens, Susan Huerta, Luisa Munoz-Price

Research output: Contribution to journalArticle

Abstract

In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.

Original languageEnglish (US)
JournalInfection Control and Hospital Epidemiology
DOIs
StateAccepted/In press - Jan 1 2018

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios'. Together they form a unique fingerprint.

Cite this